Sign in
4

Changes in Ownership

Matinas BioPharma Holdings, Inc. Filed Acc 0001493152-20-011533

Options or other derivatives

  • Chief Financial Officer acquired 175,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kucinski Keith A · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-06-17 Grant or award : show line 1 in the form Stock option (right to buy) +175,000 175,000 D
Loading xslF345X03/ownership.xml…